Healthcare provider profile · identity verified

Samir Bir Ale, MD

Family Practice · COOS BAY, OR · NPI 1447538533

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	255	65
Omeprazole	Omeprazole	223	54
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	219	29
Metformin Hcl	Metformin Hcl	195	46
Levothyroxine Sodium	Levothyroxine Sodium	194	52
Furosemide	Furosemide	191	49
Gabapentin	Gabapentin	186	43
Atorvastatin Calcium	Atorvastatin Calcium	169	48
Metoprolol Succinate	Metoprolol Succinate	164	44
Losartan Potassium	Losartan Potassium	163	53
Tamsulosin Hcl	Tamsulosin Hcl	160	46
Baclofen	Baclofen	139	43
Albuterol Sulfate Hfa	Albuterol Sulfate	132	31
Tramadol Hcl	Tramadol Hcl	132	23
Metoprolol Tartrate	Metoprolol Tartrate	124	33
Potassium Chloride	Potassium Chloride	108	28
Amlodipine Besylate	Amlodipine Besylate	105	31
Trazodone Hcl	Trazodone Hcl	105	31
Eliquis	Apixaban	104	28
Meloxicam	Meloxicam	97	30
Carvedilol	Carvedilol	96	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	89	24
Hydrochlorothiazide	Hydrochlorothiazide	88	26
Buspirone Hcl	Buspirone Hcl	87	14
Pantoprazole Sodium	Pantoprazole Sodium	79	17
Simvastatin	Simvastatin	72	18
Shingrix	Varicella-Zoster Ge/As01b/Pf	70	57
Glipizide	Glipizide	68	19
Sertraline Hcl	Sertraline Hcl	68	17
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	57	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	55	suppressed
Alprazolam	Alprazolam	54	15
Citalopram Hbr	Citalopram Hydrobromide	54	13
Montelukast Sodium	Montelukast Sodium	54	15
Escitalopram Oxalate	Escitalopram Oxalate	53	15
Alendronate Sodium	Alendronate Sodium	51	11
Warfarin Sodium	Warfarin Sodium	51	suppressed
Bupropion Hcl Sr	Bupropion Hcl	50	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	48	14
Famotidine	Famotidine	48	13
Hydroxyzine Hcl	Hydroxyzine Hcl	48	12
Duloxetine Hcl	Duloxetine Hcl	46	12
Olanzapine	Olanzapine	46	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	14
Rosuvastatin Calcium	Rosuvastatin Calcium	42	14
Spironolactone	Spironolactone	41	14
Pravastatin Sodium	Pravastatin Sodium	40	13
Allopurinol	Allopurinol	39	14
Clopidogrel	Clopidogrel Bisulfate	39	suppressed
Ventolin Hfa	Albuterol Sulfate	39	11
Aripiprazole	Aripiprazole	38	suppressed
Lorazepam	Lorazepam	38	suppressed
Fluticasone Propionate	Fluticasone Propionate	37	11
Nystatin	Nystatin	36	13
Azithromycin	Azithromycin	35	31
Clonazepam	Clonazepam	34	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	34	suppressed
Prednisone	Prednisone	33	24
Ibuprofen	Ibuprofen	31	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	12
Atenolol	Atenolol	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	17
Jardiance	Empagliflozin	29	suppressed
Levetiracetam	Levetiracetam	29	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	27	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Morphine Sulfate Er	Morphine Sulfate	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Metformin Hcl Er	Metformin Hcl	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Clobetasol Propionate	Clobetasol Propionate	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Glipizide Er	Glipizide	21	suppressed
Estradiol	Estradiol	20	suppressed
Ozempic	Semaglutide	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Finasteride	Finasteride	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Carbamazepine Er	Carbamazepine	18	suppressed
Fluconazole	Fluconazole	18	suppressed
Diazepam	Diazepam	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Lacosamide	Lacosamide	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Valsartan	Valsartan	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Cilostazol	Cilostazol	14	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Albuterol Sulfate	Albuterol Sulfate	13	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	13	13
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Brilinta	Ticagrelor	11	suppressed
Colchicine	Colchicine	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Repaglinide	Repaglinide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error